Christopher Lueking is in his thirtieth year of practice with Latham & Watkins. Mr. Lueking advises clients on corporate finance, securities, and public and private company representation, including initial public, secondary, high yield bond, and private securities offerings. He also counsels companies on securities and corporate governance matters. He is Chair of the Industrials & Manufacturing Industry Group.
Mr. Lueking's practice includes representation of issuers and investment banks in public offerings of equity and high yield debt as well as investors and issuers in venture capital transactions.
Mr. Lueking's representations in initial public offerings and other financing transactions in recent years include:
- Harmony Biosciences
- Sprout Social
- Mayville Engineering Company
- PetIQ
- Construction Partners
- John Bean Technologies Corporation
- Primo Water
- Viking Cruise Lines
- OrthoPediatrics
- NetSmart
- Duluth Holdings
- CNH Industrial Capital
- Textura Corporation
- Orbitz
- Universal Truckload Services
- Accuride Corporation
- Standard Parking Corporation
- Viasystems Group
- Eagle Pharmaceuticals
- BioDelivery Sciences International
- Meru Networks
- Pfenex
Mr. Lueking has represented a number of investment banking clients in a variety of public offering underwritings and high yield offerings during the past several years, including:
- J.P. Morgan
- Barclays
- Citigroup
- Morgan Stanley
- Bank of America/Merrill Lynch
- Credit Suisse
- William Blair & Company
- Stifel Nicolaus Weisel
- Robert W. Baird
- Goldman, Sachs & Co.
- Piper Jaffray
His ongoing representation of public and private companies in corporate governance and securities matters includes work for:
- Aon
- Cars.com
- Libbey
- Accuride Corporation
- RLI Corp.
- Guaranteed Rate
Recent Speaking Engagements
-
Latham/PwC “Going Public and Being Public – Planning a Successful IPO” seminars – Chicago, Minneapolis, Denver and Salt Lake City
- Stifel IPO seminar - New York